AMA, AAP, IDSA Among Organizations Disinvited From CDC Vaccine Workgroups
By Stephanie Brown HealthDay Reporter
Medically reviewed by Drugs.com

FRIDAY, Aug. 8, 2025 -- U.S. health officials have informed more than half a dozen leading medical organizations that they will no longer be invited to participate in developing vaccination recommendations.
Last Thursday, the American Medical Association, the American Academy of Pediatrics, the Infectious Diseases Society of America, and other medical organizations were notified via email that their experts are being removed from the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) workgroups, the Associated Press reported.
One email said the organizations are "special interest groups and therefore are expected to have a 'bias' based on their constituency and/or population that they represent."
The move is the latest in an ongoing dispute involving ACIP. Since 1964, ACIP has guided how U.S. Food and Drug Administration-approved vaccines should be used, with CDC directors typically endorsing its recommendations. These decisions shape medical practice and enable insurance coverage for vaccines.
U.S. Health Secretary Robert F. Kennedy Jr. abruptly dismissed the entire ACIP in June, alleging it was too aligned with manufacturers. He then replaced its members with a group that included several vaccine skeptics.
William Schaffner, M.D., a Vanderbilt University vaccine expert who for decades has been involved with ACIP and its workgroups, told the AP that input from professional groups ensured ACIP recommendations were practical for doctors and bolstered public trust by securing support from respected medical organizations. Workgroup members were vetted for conflicts of interest to prevent financial or other ties to the vaccines under review.
Additional organizations disinvited from the groups include the American College of Physicians, American Geriatrics Society, American Osteopathic Association, National Medical Association, and National Foundation for Infectious Diseases.
"To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines," the AMA and several of the other organizations said in a joint statement. "We strongly urge the administration to reconsider excluding our organizations from participating in the ACIP vaccine review process."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-09 12:00
Read more

- Few Discontinuation Symptoms Reported After Stopping Antidepressants
- Green Spaces Promote Better Brain Development Among Children, Study Says
- Menopause Hormone Therapy Boosts GLP-1 Drug Effectiveness, Researchers Say
- Leukemia & Lymphoma Society Changing Name to Blood Cancer United
- Verastem Oncology Granted Fast Track Designation for VS-7375 for the Treatment of KRAS G12D-mutated Locally Advanced or Metastatic Pancreatic Cancer
- Almost 15 Percent of U.S. Seniors Use Aspirin for Primary Prevention
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions